“…Besides, the administration of JWXYS (5 and 10 mg/kg, p.o.) increased allopregnanolone levels in the prefrontal cortex and hippocampus ( Qiu et al, 2015 ). Reduced levels of allopregnanolone in the peripheral blood or cerebrospinal fluid were found to be associated with major depression, anxiety disorders, premenstrual dysphoric disorder, negative symptoms in schizophrenia, or impulsive aggression.…”